WINDTREE THERAPEUTICS INC /DE/ Other Nonoperating Expense
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Other Nonoperating Expense of $622.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2016-05-12
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for the quarter ending 2016-03-31 was $622.00K, a 48.51% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for the quarter ending 2015-12-31 was $604.00K, a 49.71% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for the quarter ending 2015-09-30 was $1.50M, a 27.56% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for the quarter ending 2015-06-30 was $1.36M, a 20.16% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for fiscal 2015 was $4.67M, a 1.50% increase from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for fiscal 2014 was $4.60M, a 212.51% increase from fiscal 2013.
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for fiscal 2013 was $1.47M, a 2480.70% increase from fiscal 2012.
- WINDTREE THERAPEUTICS INC /DE/ other nonoperating expense for fiscal 2012 was $57.00K, a 119.23% increase from fiscal 2011.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2016-03-31 | $622.00K 10-Q · filed 2016-05-12 | $1.23M derived: sum of 2 quarters · filed 2016-05-12 | $2.72M derived: sum of 3 quarters · filed 2016-05-12 | $4.08M derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-12-31 | $604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $2.10M derived: sum of 2 quarters · filed 2016-03-29 | $3.46M derived: sum of 3 quarters · filed 2016-03-29 | $4.67M 10-K · filed 2016-03-29 |
| 2015-09-30 | $1.50M 10-Q · filed 2015-11-05 | $2.85M derived: sum of 2 quarters · filed 2015-11-05 | $4.06M 10-Q · filed 2015-11-05 | $5.26M derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-06-30 | $1.36M 10-Q · filed 2015-08-10 | $2.57M 10-Q · filed 2015-08-10 | $3.77M derived: sum of 3 quarters · filed 2016-05-12 | $4.94M derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-03-31 | $1.21M 10-Q · filed 2016-05-12 | $2.41M derived: sum of 2 quarters · filed 2016-05-12 | $3.58M derived: sum of 3 quarters · filed 2016-05-12 | $4.71M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $2.37M derived: sum of 2 quarters · filed 2016-03-29 | $3.50M derived: sum of 3 quarters · filed 2016-03-29 | $4.60M 10-K · filed 2016-03-29 |
| 2014-09-30 | $1.17M 10-Q · filed 2015-11-05 | $2.30M derived: sum of 2 quarters · filed 2015-11-05 | $3.40M 10-Q · filed 2015-11-05 | $3.99M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $1.13M 10-Q · filed 2015-08-10 | $2.22M 10-Q · filed 2015-08-10 | $2.82M derived: sum of 3 quarters · filed 2015-08-10 | $3.17M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $1.09M 10-Q · filed 2015-05-11 | $1.69M derived: sum of 2 quarters · filed 2015-05-11 | $2.04M derived: sum of 3 quarters · filed 2015-05-11 | $2.39M derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $951.00K derived: sum of 2 quarters · filed 2015-03-16 | $1.29M derived: sum of 3 quarters · filed 2015-03-16 | $1.47M 10-K · filed 2015-03-16 |
| 2013-09-30 | $353.00K 10-Q · filed 2014-11-07 | $696.00K derived: sum of 2 quarters · filed 2014-11-07 | $873.00K 10-Q · filed 2014-11-07 | $883.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $343.00K 10-Q · filed 2014-08-07 | $520.00K 10-Q · filed 2014-08-07 | $530.00K derived: sum of 3 quarters · filed 2015-03-16 | $570.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $178.00K 10-Q · filed 2014-05-12 | $187.00K derived: sum of 2 quarters · filed 2015-03-16 | $227.00K derived: sum of 3 quarters · filed 2015-03-16 | $231.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $49.00K derived: sum of 2 quarters · filed 2015-03-16 | $53.00K derived: sum of 3 quarters · filed 2015-03-16 | $57.00K 10-K · filed 2015-03-16 |
| 2012-09-30 | $40.00K 10-Q · filed 2012-11-14 | $44.00K derived: sum of 2 quarters · filed 2012-11-14 | $48.00K 10-Q · filed 2012-11-14 | $52.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $4.00K 10-Q · filed 2012-08-14 | $8.00K 10-Q · filed 2012-08-14 | $12.00K derived: sum of 3 quarters · filed 2014-03-17 | $18.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $4.00K 10-Q · filed 2013-05-07 | $8.00K derived: sum of 2 quarters · filed 2014-03-17 | $14.00K derived: sum of 3 quarters · filed 2014-03-17 | $20.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $10.00K derived: sum of 2 quarters · filed 2014-03-17 | $16.00K derived: sum of 3 quarters · filed 2014-03-17 | $26.00K 10-K · filed 2014-03-17 |
| 2011-09-30 | $6.00K 10-Q · filed 2012-11-14 | $12.00K derived: sum of 2 quarters · filed 2012-11-14 | $22.00K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $6.00K 10-Q · filed 2012-08-14 | $16.00K 10-Q · filed 2012-08-14 | ||
| 2010-12-31 | $357.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |